Low Blood Sugar May Be Associated With COPD

The claim that low blood sugar may be associated with copd needs unpacking rather than repeating. Blood glucose problems are common in lung disease, but the usual direction is upward, not downward. This guide explains where hypoglycemia genuinely comes from and what to do about it.

Chronic Obstructive Pulmonary Disease, or COPD, is a progressive lung disease that affects millions worldwide. Breathing difficulties, chronic cough, and other respiratory disorders define it. Although the core concept of COPD management lies in improving lung function and quality of life, more recent evidence indicates that systemic abnormalities, such as metabolic disorders like hypoglycemia, are related to the progression and clinical course of the disease in patients.
In this Blog, we’ll discuss in detail how low blood sugar may be associated with COPD.

Understanding COPD and its systemic effects

COPD has always been associated with systemic inflammation and oxidative stress. These factors affect the lungs and most of the body’s systems, such as metabolism. Disease conditions involve cardiovascular disease, diabetes, and muscle wasting. Given such relationships between respiratory and metabolic health, it is worth investigating how low blood sugar may affect COPD. Symptoms include persistent wheezing, chest infection, shortness of breath, and a chesty cough with phlegm that does not go away.

What Is Low Blood Sugar?

Hypoglycemia is when blood glucose levels fall below the normal range, usually less than 70 mg/dL. Symptoms of hypoglycemia can be mild or severe and include the following:

• Shaking or trembling
• Sweating
• Dizziness or lightheadedness
• Confusion
• Irritability or mood changes
• Rapid heartbeat

Severe hypoglycemia can cause seizures, unconsciousness, and even death if left untreated.

The Relationship Between COPD and Low Blood Sugar

Although COPD and hypoglycemia are two different diseases, some factors may connect to the former:

Corticosteroid Treatment

Corticosteroids are given to patients with COPD, decreasing inflammation and preventing its exacerbation. Long-term administration leads to resistance to insulin and changes in blood sugar levels. That may make some patients prone to hypoglycemia, especially when taken along with other drugs such as bronchodilators or beta-blockers.

Reduced Physical Activity

Many patients with COPD end up with low mobility related to breathlessness and severe fatigue. A sedentary lifestyle may influence metabolic pathways for glucose, where there is increased sensitivity toward insulin, thus increasing the risk for hypoglycemia.

Nutrition Deficiencies

Weight loss and malnutrition occur largely in patients with COPD. These conditions reduce glycogen levels inside the body and compromise its efforts to maintain normal blood sugar levels when fasting or ingesting decreasing calories.

Hypermetabolism

COPD often results in high energy expenditure due to labored breathing. This usually leads to an imbalance between energy intake and output, and blood sugar drops frequently occur, especially if dietary intake is inadequate.

Comorbid Conditions

Another major comorbidity observed in patients suffering from COPD is diabetes. The presence of COPD complicates the management of diabetes, and this combination can create difficulties in avoiding hypoglycemic episodes while administering treatment for both.

Overlapping Symptoms Hypoglycemia and COPD

It is difficult to diagnose hypoglycemia in patients suffering from COPD because the symptoms are dizziness, fatigue, and confusion, which are all the same symptoms that characterize exacerbations. This requires careful monitoring and differential diagnosis for the appropriate treatment.

Management of Hypoglycemia in COPD Patients

Management of hypoglycemia in patients suffering from COPD is holistic.

• Regular Checkup: COPD patients, particularly those who are diabetic or on a course of corticosteroids, should closely monitor their blood sugar levels with the help of CGM Devices.
• Balanced Diet: The diet must contain complex carbohydrates, proteins, and healthy fats. Patients who expend most of their energy can benefit from frequent, small-sized meals that control the sugar levels present in their blood.
• Medication Adjustment: Patients may need corticosteroid dose adjustment or changes in diabetes medication as supervised by a physician to prevent hypoglycemia.
• Exercise Planning: It is good to exercise, but one should do it according to the patient’s capacity and monitor him/her for sudden drops in blood sugar.
• Education and Awareness: Patients and caregivers should be informed about the signs of hypoglycemia and prompt management.

Need for More Research

Although the potential link between COPD and low blood sugar is quite appealing, further research is required to determine the mechanisms and implications of this association. Some research could be conducted on how different treatments affect blood sugar levels and the long-term results of managing hypoglycemia in COPD patients.

PGx Testing for Managing Low Blood Sugar in COPD

Pharmacogenomic (PGx) testing of Pharmacogenomic testing does not manage low blood sugar in COPD, and there is no genetic guidance for inhalers or oral steroids. Glucose monitoring, adjusting diabetes doses around steroid courses and nutrition are what make the difference. COPD treatment often involves corticosteroids and other medications that can influence glucose metabolism, potentially leading to hypoglycemia.

PGx testing helps identify genetic variations that affect drug metabolism, efficacy, and side effects, allowing for personalized adjustments to medication choices and dosages. For example, PGx testing can advise on a safe administration of corticosteroids or diabetes in a patient with COPD without risking the potential to fluctuate blood sugars.

Low blood sugar may be associated with copd, but indirectly

Start with the correction, because the earlier version of this article implied something misleading. Corticosteroids, which are widely used in COPD, usually raise blood glucose rather than lower it. Steroid-induced hyperglycemia is common and well documented.

So when low blood sugar may be associated with copd, the association almost always runs through something else: a diabetes medicine, poor intake during illness, advanced liver or kidney disease, adrenal insufficiency after long steroid use, or severe illness itself.

• Insulin or sulfonylureas taken while eating less during an exacerbation.
• Steroids started for a flare, diabetes doses increased to compensate, then steroids stopped abruptly while the higher doses continue.
• Malnutrition and muscle loss, which reduce the glycogen buffer the body draws on between meals.
• Adrenal suppression after repeated or prolonged steroid courses, which blunts the hormonal response to falling glucose.
• Critical illness, sepsis and liver failure, where hypoglycemia is an ominous sign rather than a nuisance.

That is a more useful map than saying low blood sugar may be associated with copd, because each route has a specific fix. None of them is a reason to skip prescribed steroids during a flare, which treat a dangerous problem.

Hypoglycemia symptoms and why they hide in lung disease

Hypoglycemia symptoms start below a blood glucose of about 70 mg/dL, with severe hypoglycemia being any episode needing another person’s help.

• Early hypoglycemia symptoms come from adrenaline: shakiness, sweating, palpitations, hunger, anxiety and tingling around the mouth.
• Later symptoms come from the brain running short of fuel: confusion, slurred speech, blurred vision, drowsiness, odd behavior, seizures and loss of consciousness.
• Night-time episodes show up as vivid dreams, sweating, morning headache or waking unrefreshed.
• Hypoglycemia unawareness develops when episodes are frequent, and the warning symptoms disappear.

The overlap with a copd exacerbation is the practical problem. Breathlessness, anxiety, sweating, palpitations and confusion all occur during a copd exacerbation and during low oxygen states, so hypoglycemia symptoms are easy to attribute to the lungs and miss entirely.

The rule that solves it is simple: if someone at risk becomes confused, drowsy or unusually agitated, check the glucose rather than assuming. It takes seconds and it changes the treatment completely.

Treating a low, safely

If hypoglycemia symptoms appear and the person is awake and able to swallow, the standard approach is well established and worth memorizing.

1. Take about 15 grams of fast-acting carbohydrate, such as glucose tablets, half a cup of juice or regular soda, or a tablespoon of sugar or honey.
2. Wait 15 minutes and recheck the glucose.
3. Repeat if it is still below 70 mg/dL.
4. Once it is back above 70, follow with a snack containing protein and complex carbohydrate if the next meal is more than an hour away.
5. Record what happened and tell your clinician, because repeated lows mean a medication plan needs changing.

If the person cannot swallow safely, is unconscious or is having a seizure, do not put anything in their mouth. Give glucagon if it is prescribed and you know how, and call 911 in the United States. Poison Control is 1-800-222-1222 for advice about medication errors.

Never adjust insulin or diabetes tablets on your own after an episode. Bring the pattern to your prescriber, who can change the regimen properly. That is particularly important around steroid courses, when doses often need to go up and then back down on a plan.

Corticosteroids and blood sugar during a flare

Corticosteroids and blood sugar interact in a predictable way. Steroids increase glucose production in the liver and reduce the effect of insulin, so levels rise, typically most noticeably in the afternoon and evening after a morning dose.

Corticosteroids and blood sugar matter for anyone with diabetes or prediabetes. Short courses for a copd exacerbation can push glucose high enough to cause symptoms, dehydration and, rarely, a hyperosmolar emergency. Monitoring is usually increased during and shortly after a course.

• Ask whether to check glucose more often while taking steroids, and what number should prompt a call.
• Ask what happens to your diabetes doses when the steroid course ends, since that is when lows occur.
• Watch for thirst, frequent urination and blurred vision during the course.
• Tell every prescriber about repeated steroid courses, because adrenal suppression is a real consequence of frequent or prolonged use.
• Inhaled steroids have far smaller systemic effects than tablets, though high doses are not entirely free of them.

None of this is a reason to avoid steroids when they are indicated. Systemic corticosteroids shorten recovery and reduce treatment failure in a copd exacerbation, and the glucose effect is managed rather than avoided.

Copd and diabetes together

Copd and diabetes coexist more often than chance would predict, and each makes the other harder to manage.

• Shared risk factors, particularly smoking, which raises risk for both.
• Systemic inflammation associated with COPD is linked with insulin resistance.
• Reduced activity from breathlessness worsens glucose control and muscle mass.
• Repeated steroid courses push glucose up over time.
• Poor glucose control is associated with more frequent chest infections, which drive more exacerbations.

Managing copd and diabetes overlaps neatly, which is the encouraging part. Stopping smoking, pulmonary rehabilitation, vaccination against influenza, pneumococcus, COVID-19 and RSV where recommended, good inhaler technique and an agreed action plan all help both conditions.

Nutrition deserves attention in copd and diabetes too. Weight loss and muscle wasting are common in advanced COPD and are associated with worse outcomes, so a dietitian referral is reasonable when appetite is poor or weight is falling. Small frequent meals are often easier than large ones when breathing is hard work.

Warning signs that need urgent care

A copd exacerbation and a severe low both have red flags, and knowing them prevents the delay that turns a manageable problem into an admission.

• Breathlessness at rest that is worse than your usual, new confusion, blue lips or fingertips, or drowsiness: seek emergency care.
• A copd exacerbation with fever, chest pain or coughing blood needs same-day assessment.
• Severe hypoglycemia, or any episode needing another person’s help, needs medical review even if it resolves.
• Repeated lows, or lows without warning symptoms, mean the regimen is wrong and needs changing promptly.
• Glucose that stays very high with thirst, vomiting or drowsiness needs urgent assessment.

In the United States, call 911 for emergencies. Keep a written action plan for your lungs and, if you use insulin or sulfonylureas, a written plan for lows, including who to call and when.

Does pharmacogenomics have a role here?

A small and honest one, and it is not about whether low blood sugar may be associated with copd. There is no pharmacogenomic guidance for inhaled bronchodilators or inhaled corticosteroids, and none for the oral steroids used in a flare.

On the diabetes side, CYP2C9 variants affect the clearance of sulfonylureas such as glipizide and glyburide, and reduced-function variants are associated with higher exposure. That association is studied but there is no widely adopted prescribing guideline, so it is context rather than instruction.

Where a panel is genuinely useful for people with COPD is the rest of the medicine list, which is usually long: antidepressants, statins guided by SLCO1B1, anticoagulants guided by CYP2C9 and VKORC1, and pain medicines guided by CYP2D6. Polypharmacy, not lung disease, is the reason to consider testing.

The RPh Labs panel covers 20 genes reported against more than 240 medications, using an at-home cheek swab with each report reviewed by a PharmD pharmacist. See the testing kit page and the medication list by gene, and check the FDA table of pharmacogenomic biomarkers in drug labeling for what is on a label. Never change a diabetes or steroid dose based on a report without your prescriber.

Conclusion

COPD is a complex systemic disease, and this novel association with low blood glucose further underscores the complex relationship between respiratory and metabolic well-being. Recognition and treatment of hypoglycemia in patients diagnosed with COPD can enhance their overall management and outcome at the hands of clinicians. The need for a truly multidisciplinary approach to care comes full circle relating to respiratory, nutritional, and metabolic expertise.

Where pharmacogenomic testing helps people with COPD is the rest of a long medicine list, such as statins guided by SLCO1B1, anticoagulants guided by CYP2C9 and VKORC1, and antidepressants guided by CYP2D6 and CYP2C19. It does not guide inhalers, steroids or blood sugar management.

Low blood sugar may be associated with copd: FAQ

Can COPD cause hypoglycemia or low blood sugar?

No, COPD itself is not the reason for hypoglycemia. In patients suffering from COPD, the possibility of hypoglycemia is caused by corticosteroid therapy, a decrease in activity level, malnutrition, and co-morbid conditions such as diabetes.

What are the symptoms of hypoglycemia in patients with COPD?

Common symptoms include shakiness, sweating, dizziness, confusion, irritability, and a racing heart. These symptoms can mimic an exacerbation of COPD, making careful monitoring essential.

What is the effect of corticosteroid therapy in COPD on blood glucose?

Long-term corticosteroids may result in insulin resistance and blood glucose fluctuation, and this risk of hypoglycemia or hyperglycemia may be higher if this drug is used along with other medications.

Can a personalized diet help COPD patients to prevent hypoglycemia?

Yes, a well-balanced diet rich in complex carbohydrates, proteins, and good fats and small, frequent meals might help control the fluctuating blood glucose level in COPD patients. That is because a normal amount of energy will also be consumed.

What is the PGx testing for management of low blood sugar in COPD?

PGx testing identifies genetic variations affecting drug metabolism and response to tailor the treatment to avoid the risk of hypoglycemia and maximize disease control.

Do steroids for COPD cause low blood sugar?

Usually the opposite. Corticosteroids and blood sugar interact by raising glucose, and steroid-induced hyperglycemia is common. Lows more often follow the end of a steroid course when diabetes doses were increased and not reduced again.

What hypoglycemia symptoms should I watch for?

Shakiness, sweating, palpitations, hunger and anxiety first, then confusion, slurred speech, drowsiness, seizures or loss of consciousness. These overlap with breathlessness and low oxygen, so check the glucose rather than assuming it is the lungs.

How do I treat a low safely?

If awake and able to swallow, take about 15 grams of fast-acting carbohydrate, wait 15 minutes, recheck, and repeat if still below 70 mg/dL. If unconscious or seizing, give prescribed glucagon if trained and call 911.

Why do copd and diabetes occur together so often?

Shared risk factors such as smoking, systemic inflammation linked to insulin resistance, reduced activity from breathlessness, and repeated steroid courses. Poor glucose control also raises infection risk, which drives more exacerbations.

Should I stop steroids during a copd exacerbation if my sugar rises?

No. Systemic corticosteroids shorten recovery and reduce treatment failure in a flare. The glucose rise is managed with closer monitoring and a plan for adjusting diabetes doses, set by your prescriber rather than by you.

Does genetic testing help with COPD medicines?

Not for inhalers or oral steroids, which have no pharmacogenomic guidance. CYP2C9 affects sulfonylurea clearance as context. Testing is more relevant to the rest of a long medicine list, such as statins, anticoagulants and antidepressants.